Campylobacter Blood-Free Selective Medium (Modified CCDA)

Hazard statements (CLP)

H351

Code

Statements

H351

Suspected of causing cancer

SECTION 2: Hazards identification

Classification of the substance or mixture Classification according to GB CLP (SI 2019:720 as amended) Carcinogenicity, Category 2 H351 Full text of H- and EUH-statements: see section 16

Adverse physicochemical, human health and environmental effects

No additional information available

2.2 Label elements

Labelling according to GB CLP (SI 2019:720 as amended)

Hazard pictograms

(GB CLP) GHS08

Signal word

(GB CLP) Warning

Contains

Carbon black

Hazard statements

(GB CLP) H351 - Suspected of causing cancer.

Precautionary statements

(GB CLP) P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing, eye protection, face protection and hearing protection. P308+P313 - IF exposed or concerned: Get medical advice or attention. P405 - Store locked up. P501 - Dispose of contents and container to a hazardous or special waste collection point, in accordance with local, regional, national and international regulations.

Results of PBT and vPvB assessment

Component Substance(s) not meeting the PBT criteria of UK Charcoal, activated (7440-44-0), Carbon black (1333-86-4), Sodium deoxycholate (302- REACH regulation, in accordance with Annex XIII 95-4), Magnesium sulfate anhydrous (7487-88-9), Iron(II) sulfate heptahydrate (7782-63- 0) Substance(s) not meeting the vPvB criteria of UK Charcoal, activated (7440-44-0), Carbon black (1333-86-4), Sodium deoxycholate (302- REACH regulation, in accordance with Annex XIII 95-4), Magnesium sulfate anhydrous (7487-88-9), Iron(II) sulfate heptahydrate (7782-63- 0) Results of Endocrine Disruptor assessment Component Substance(s) not considered as endocrine disrupting. Charcoal, activated(7440-44-0), Carbon black(1333-86-4), Sodium deoxycholate(302-95- They are not included in the list established in 4), Magnesium sulfate anhydrous(7487-88-9), Iron(II) sulfate heptahydrate(7782-63-0) accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, nor identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP

2.1 Classification of the substance or mixture

Classification according to GB CLP (SI 2019:720 as amended) Carcinogenicity, Category 2 H351 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available